Clinical
Discovery
Leif Schauser // Tuesday, May 21, 2019

How to accurately quantify miRNAs and increase the fraction of miRNA-annotated reads

Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…


Clinical
QIAGEN Bioinformatics // Wednesday, May 15, 2019

Using liquid biopsy to guide clinical trial enrollment for patients with cancer

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…


Discovery
Paula Tataru // Tuesday, April 9, 2019

Comparative Analysis of Whole Genomes using CLC Workbenches

  Introducing the Whole Genome Alignment Plugin Paula Tataru, Ph.D, Senior Bioinformatics Scientist   The new Whole Genome Alignment plugin,…


Clinical
QIAGEN Bioinformatics // Wednesday, April 3, 2019

HGMD 2019.1 hits major milestone

Over a quarter million germline mutations catalogued   HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD…


Discovery
Winnie Ridderberg // Wednesday, March 20, 2019

Detecting antimicrobial resistance causing mutations using a custom-designed variant database

In a recent blog post we shared exciting news on new functionalities for detecting antimicrobial resistance (AMR) implemented within CLC…


Discovery
Thomas Poulsen // Tuesday, March 19, 2019

Structural Variant Detection using CLC Genomics Workbench

Introduction to the Advanced Structural Variant Detection plugin for the CLC Genomics Workbench Structural variants affect large regions of the…


Discovery
Leif Schauser // Friday, February 15, 2019

Transcript Discovery using CLC Genomics Workbench

Introduction to the Transcript Discovery Plugin Leif Schauser, PhD, Director Product Management Genome Analysis Bioinformatics – CLC Transcript discovery using…


Discovery
Winnie Ridderberg // Tuesday, February 5, 2019

Find New Genomic Insights into Antimicrobial Resistance

Find resistance through surveillance and source tracing with two new tools: PointFinder and ShortBRED Winnie Ridderberg, PhD, Senior Scientist, Microbial…


Clinical
QIAGEN Bioinformatics // Monday, February 4, 2019

New momentum for harmonizing TMB results

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…


Clinical
QIAGEN Bioinformatics // Sunday, February 3, 2019

QIAGEN Conversations

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…


Clinical
QIAGEN Bioinformatics // Wednesday, January 30, 2019

Driving real-world impact with N-of-One, now a QIAGEN company

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…


Events
QIAGEN Bioinformatics // Wednesday, January 30, 2019

What was all the real-world evidence buzz at PMWC 2019?

With great networking opportunities, exciting panel discussions, and a packed exhibit hall, Precision Medicine World Conference 2019 was the place…

© QIAGEN 2019. All rights reserved - Trademarks & Disclaimers